Information on a UK multicentre study evaluating the use of Peptest for patients with laryngopharyngeal reflux (LPR) will be presented at a world-class laryngology conference this month.

The Cutting Edge Laryngology Conference showcases the most up-to-date advances in understanding, diagnosing and managing laryngeal disorders.

Taking place at the Royal College of Surgeons of Edinburgh on 25-27 September 2019, the three-day conference will be attended by key figures from the international laryngology community and the agenda includes panel discussions, interactive poster sessions and keynote speeches.

Ear, nose and throat (ENT) specialist Julian McGlashan, who uses Peptest in the ENT department at the Queen’s Medical Centre (QMC) in Nottingham, will give an oral presentation presenting the results of a multicentre study carried out in UK voice clinics evaluating the non-invasive reflux diagnostic Peptest in LPR patients.

In summary, the study highlights how ‘Patients across all five UK voice centres showed high prevalence of salivary pepsin with an overall sensitivity of 76 per cent. Pepsin was shown to be an ideal biomarker for detecting airway reflux and LPR.’

Our UK distributor Biohit will also be attending the conference, alongside our lab manager Andrew Woodcock.

If you would like to arrange a chat during the conference, please drop us a line here.